Antioxidant treatment of tardive dyskinesia

Prostaglandins Leukot Essent Fatty Acids. 1996 Aug;55(1-2):77-81. doi: 10.1016/s0952-3278(96)90149-0.

Abstract

Tardive dyskinesia (TD) is a frequently occurring side effect of treatment with neuroleptic antipsychotic drugs. TD is a persistent and often irreversible syndrome characterized by abnormal movements, including lingual and orofacial dyskinesia, grimacing, tics, choreic movements of the limbs and trunk, and athetosis and dystonia. In some patients the muscles of respiration and speech may also be involved. There is no established treatment for TD.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Antioxidants / therapeutic use*
  • Dyskinesia, Drug-Induced / drug therapy*
  • Dyskinesia, Drug-Induced / epidemiology
  • Free Radicals
  • Humans
  • Prevalence
  • Reactive Oxygen Species*

Substances

  • Antioxidants
  • Free Radicals
  • Reactive Oxygen Species